• Videos of the event

    Did you miss the Cardiology Expert Symposium 2021? Do you want to (re)watch a talk from the webinar? Watch the talks from Professor Azfar Zaman, Professor Robert Storey, Doctor Derek Connolly and Doctor Vijay Kunadian.

    To ensure you do not miss our future events, please sign up for email updates

    Cardiovascular Time Bomb and Managing Cardiometabolic Risk in the post-ACS patient

    Prof Robert Storey discusses management of cardiovascular risk in the post-ACS patient, outlining the common modifiable cardiovascular disease risk factors and the current guideline recommended treatment options for thrombosis, lipids, blood pressure, left ventricular dysfunction/heart failure/arrhythmia risk and glycaemic control1 .

    Global burden of CVD in Women

    Dr Vijay Kunadian outlines the global burden of cardiovascular disease in women and that despite efforts to raise awareness of this, cardiovascular disease in women remains understudied, under-recognised, underdiagnosed, and undertreated. She then discusses a series of recommendations from an international team of experts and leaders in the field who, as part of a Lancet Commission, have a clear focus to reduce the global burden of cardiovascular disease in women by 20302.

    Modern LDL-C management post-ACS

    Dr Derek Connolly discusses modern LDL-C management in the post-ACS patient, outlining the current unmet need/ residual cardiovascular risk and the clinical evidence and guideline recommendations for early intensive combination lipid lowering therapies, including high intensity statins, ezetimibe and PCSK9 inhibitors3 .

    Want to join the next event?

    Sign up for email updates or talk to your local contact person

    1. Visseren FLJ et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337
    2. Vogel B et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021 Jun 19;397(10292):2385-2438
    3. Mach F et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020 Jan 1;41(1):111-188